Effectiveness of nifedipine compared with other antihypertension

Nifedipine has better effectiveness in lowering blood pressure compared to other antihypertensives such as IV labetalol, oral labet alol, IV hydralazine, methyldopa in the treatment of preeclampsia, severe preeclamping, severe pre-eclampsian, chronic hypertension, hypertension emergency, and severe hypertension. Hypertension is the most common complication of pregnancy. It is a major cause of maternal, fetal, and neonatal morbidity and mortality. In this article, the effectiveness of nifedipine compared with other antihypertensives in pregnant women with hypertension was reviewed. The randomized control trial (RCT) of nifedipine and other antihypertension in pregnancy without complications published from 2016 to 2021 in Google Scholar, Cochrane and PubMed were gathered. It was reported that antihypertensives administration to pregnant women with hypertension was very meaningful both for the mother herself and for the fetus or baby. Furthermore, nifedipine has better effectiveness in lowering blood pressure compared to other antihypertensives such as IV labetalol, oral labetalol, IV hydralazine, methyldopa in the treatment of preeclampsia, severe preeclampsia, severe pre-eclampsia/eclampsia, chronic hypertension, hypertension emergency, and severe hypertension.

Full article: Comparison of ambulatory blood pressure-lowering

PDF) Oral Nifedipine Versus Intravenous Labetalol for Severe

Effectiveness of nifedipine, labetalol, and

PDF) Persistence of the antihypertensive efficacy of amlodipine

PDF) Effectiveness of combination therapy with nifedipine GITS: A

Frontiers The Antihypertensive Drug Nifedipine Modulates the

Long-term safety and efficacy of high-dose controlled-release

Frontiers Pharmaceutical administration for severe hypertension

Clinical efficacy of various anti-hypertensive regimens in

PDF) Comparison of the Efficacy of Nifedipine and Hydralazine in

PDF) Oral nifedipine versus intravenous labetalol for severe

Nifedipine Extended-Release Tablets, USP 30mg, 60mg and 90mg

A randomized controlled trial on the blood pressure–lowering